April 13, 2020 07:01 AM EDTUpdated 01:01 PM

Covid-19 roundup: Trial of Trump's favorite Covid-19 drug nixed on early death risk; Is Anthony Fauci on thin ice with the president?

Amber Tong

Senior Editor

John Carroll

Editor & Founder

A study involving one of President Trump’s favorite Covid-19 drugs had to be halted early after researchers determined that the high dose of the treatment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Trial of Trump's favorite Covid-19 drug nixed on early death risk; Is Anthony Fauci on thin ice with the president?

Amber Tong

Senior Editor

John Carroll

Editor & Founder

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Covid-19 roundup: Tri­al of Trump's fa­vorite Covid-19 drug nixed on ear­ly death risk; Is An­tho­ny Fau­ci on thin ice with the pres­i­dent?

Senior Editor

Editor & Founder

Sign up to read this article for free.

Covid-19 roundup: Trial of Trump's favorite Covid-19 drug nixed on early death risk; Is Anthony Fauci on thin ice with the president?